Hypokalemic periodic paralysis

A rare disorder characterised by episodes of muscle paralysis lasting from a few to 24-48 hours and associated with a fall in blood potassium levels.

Muscle weakness

Reduced strength of muscles.


合計: 17

                      


(表示件数)
PMID (PMCID)
28255549
(5314262)
OTHER
Rhabdomyolysis following severe hypokalemia caused by familial hypokalemic periodic paralysis.
Jung YL, Kang JY.
World J Clin Cases. 2017;5(2):56-60.
A 30-year-old woman who had 3 episodic attacks of hypokalemic periodic paralysis was admitted in emergency room with sudden onset symmetrical muscle weakness.
28255549
(5314262)
OTHER
Rhabdomyolysis following severe hypokalemia caused by familial hypokalemic periodic paralysis.
Jung YL, Kang JY.
World J Clin Cases. 2017;5(2):56-60.
Primary hypokalemic periodic paralysis is a rare genetic disease characterized by episodic attacks of muscle weakness due to decreases in serum potassium.
26433613
MIXED_SAMPLE Adult
The R900S mutation in CACNA1S associated with hypokalemic periodic paralysis.
Ke Q, He F, Lu L, Yu P, Jiang Y, Weng C, Huang H, Yi X, Qi M.
Neuromuscul Disord. 2015;25(12):955-8.
We first present a clinical description of hypokalemic periodic paralysis patients harboring CACNA1SR900S mutations: they were non-responsive to acetazolamide, but combined treatment with triamterene and potassium supplements decreased the frequency of muscle weakness attacks.
21171065
MALE Child
Treatment of hypokalemic periodic paralysis with topiramate.
Fiore DM, Strober JB.
Muscle Nerve. 2011;43(1):127-9.
Hypokalemic periodic paralysis (hypoPP), the most common form of periodic paralysis, is a disorder characterized by attacks of transient muscle weakness associated with a drop in serum potassium level.The mainstay of treatment is potassium supplementation and drugs that inhibit the enzyme carbonic anhydrase.
21043388
MALE
Hypokalemic periodic paralysis due to the SCN4A R672H mutation in a Turkish family.
Incecik F, Herguner MO, Altunbasak S, Lehman-Horn F.
Turk J Pediatr. 2010;52(4):409-10.
Hypokalemic periodic paralysis (HypoPP) is an autosomal dominant disorder characterized by episodic attacks of muscle weakness associated with a decrease in blood potassium levels.
19822448
MALE
Severe respiratory phenotype caused by a de novo Arg528Gly mutation in the CACNA1S gene in a patient with hypokalemic periodic paralysis.
Kil TH, Kim JB.
Eur J Paediatr Neurol. 2010;14(3):278-81.
Hypokalemic periodic paralysis (HOKPP) is a rare disorder characterized by episodic muscle weakness with hypokalemia.
19708131
MALE Adult
Atypical arrhythmic complications in familial hypokalemic periodic paralysis.
Maffe S, Signorotti F, Perucca A, Bielli M, Hladnik U, Ragazzoni E, Maduli E, Paffoni P, Dellavesa P, Paino AM, Zenone F, Parravicini U, Pardo NF, Cucchi L, Zanetta M.
J Cardiovasc Med (Hagerstown). 2009;10(1):68-71.
Familial hypokalemic periodic paralysis is an autosomal dominant muscle disorder characterized by episodic attacks of muscle weakness, accompanied by a decrease in blood potassium levels.
20396605
MALE Middle Aged
A patient suffering from hypokalemic periodic paralysis is deficient in skeletal muscle ATP-sensitive K channels.
Jovanovic S, Du Q, Mukhopadhyay S, Swingler R, Buckley R, McEachen J, Jovanovic A.
Clin Transl Sci. 2008;1(1):71-4.
Hypokalemic periodic paralysis (HOPP) is a rare disease associated with attacks of muscle weakness and hypokalemia.
19069684
MIXED_SAMPLE Adult
[Hypoglycaemic periodic paralysis in hyperthyroidism patients].
Kratochvil J, Masopust J, Martinkova V, Charvat J.
Vnitr Lek. 2008;54(11):1100-1.
Hypokalemic periodic paralysis (HPP) is a rare disorder characterised by acute, potentially fatal atacks of muscle weakness or paralysis.
17556873
MALE Adult
Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency.
Lanzi R, Previtali SC, Sansone V, Scavini M, Fortunato M, Gatti E, Meola G, Bosi E, Losa M.
J Endocrinol Invest. 2007;30(4):341-5.
Hypokalemic periodic paralysis (HypoPP) is a rare disorder consisting of sudden episodes of muscle weakness with areflexia involving all four limbs, which spontaneously resolve within several hours or days.
15716625
(2808567)
MIXED_SAMPLE
A Korean family of hypokalemic periodic paralysis with mutation in a voltage-gated calcium channel (R1239G).
Kim JB, Lee KY, Hur JK.
J Korean Med Sci. 2005;20(1):162-5.
Hypokalemic periodic paralysis (HOPP) is a rare disease characterized by reversible attacks of muscle weakness accompanied by episodic hypokalemia.
15098604
MALE
A family of hypokalemic periodic paralysis with CACNA1S gene mutation showing incomplete penetrance in women.
Kawamura S, Ikeda Y, Tomita K, Watanabe N, Seki K.
Intern Med. 2004;43(3):218-22.
Familial hypokalemic periodic paralysis is an autosomal dominant genetic muscle disease characterized by periodic attacks of muscle weakness associated with a decrease in serum potassium.
14509222
FEMALE Adult
[A case of pseudo-Bartter's syndrome induced by long-term ingestion of furosemide delivered orally through health tea].
Numabe A, Ogata A, Abe M, Takahashi M, Kono K, Arakawa M, Ishimitsu T, Ieiri T, Matsuoka H, Yagi S.
Nihon Jinzo Gakkai Shi. 2003;45(5):457-63.
A 32-year-old woman with a three-year history of muscle weakness and hypokalemia, was admitted to our hospital because of hypokalemic periodic paralysis.
12322805
MALE Middle Aged
Acetazolamide-induced muscle weakness in hypokalemic periodic paralysis.
Ikeda K, Iwasaki Y, Kinoshita M, Yabuki D, Igarashi O, Ichikawa Y, Satoyoshi E.
Intern Med. 2002;41(9):743-5.
A 46-year-old man with hypokalemic periodic paralysis (HypoPP) and diabetes mellitus (DM) had worsened muscle weakness after acetazolamide (ACZ) treatment.
12058413
MALE Adult
[Generalized muscle weakness mimicking periodic paralysis in a patient with toluene abuse].
Kamiyoshi S, Takagi R, Kihira T, Miwa H, Kondo T.
No To Shinkei. 2002;54(5):427-30.
In addition, it should be kept in mind that hypokalemic muscle weakness can be induced by the renal tubular acidosis resulting from chronic toluene exposure, and that it is by no means easy to distinguish hypokalemic periodic paralysis if it occurs recurrently.
9551533
MALE Middle Aged
[Hypokalemic periodic paralysis: new advances].
Cattaneo FA.
Schweiz Med Wochenschr. 1998;128(8):297-301.
Once diagnosis of hypokalemic periodic paralysis is established, treatment and regular follow-up are necessary to prevent the development of permanent muscle weakness.
6855804
MALE Adult
Treatment of "permanent" muscle weakness in familial Hypokalemic Periodic Paralysis.
Dalakas MC, Engel WK.
Muscle Nerve. 1983;6(3):182-6.
Three patients with Hypokalemic Periodic Paralysis (HOPP)-associated progressive interattack muscle weakness, who became unresponsive or worsened by acetazolamide, responded favorably to dichlorophenamide, a more potent carbonic anhydrase inhibitor.